A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced Malignancies
Clinical trial NCT05048134 · TERMINATED
Trial details
- NCT number
- NCT05048134
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2023-02-24
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.